Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 27, 2026
Why Is Zscaler (ZS) Stock Down -24% Today?

Why Is Zscaler (ZS) Stock Down -24% Today?

Key Takeaways

  • Shares of ZS are down approximately 24% in trading on May 27, 2026, representing one of the steepest single-session declines in the company's history as a public company
  • The primary catalyst is a dramatic, unexpected cut to Zscaler's full-year fiscal 2026 free cash flow margin guidance, slashed to 22.8%–23.3% from prior guidance of 26.5%–27%, a reduction of roughly 350–425 basis points
  • The guidance cut was driven by capital expenditures accelerating into the high single digits as a percentage of revenue — a structural shift that contradicts the capital-light cloud narrative underpinning ZS's premium valuation
  • Despite beating Q3 FY2026 revenue estimates ($850.5 million vs. ~$836 million expected) and raising full-year revenue and EPS outlooks, investors focused squarely on the cash flow deterioration
  • Organic ARR growth, excluding recent acquisitions, trails headline figures, adding a secondary concern around the sustainability of growth
  • Traders are now watching whether management can contain CapEx in Q4 FY2026, restore free cash flow margins, and clarify the investment thesis heading into the fiscal year-end

Opening Summary

Zscaler, Inc. (ZS) is a cloud-native cybersecurity company headquartered in San Jose, California, delivering Zero Trust network security, secure web gateways, and cloud access security broker solutions to thousands of enterprises worldwide. On May 27, 2026, shares plunged approximately 24%, trading near $140.30, down from the prior session's closing price of $184.60. The selloff was triggered after-hours on May 26 when Zscaler released its fiscal third-quarter 2026 results — results that beat on revenue and earnings per share but contained a deeply disappointing cut to annual free cash flow guidance that alarmed investors and sent the stock spiraling.

Free Cash Flow Guidance: The Core Catalyst

The single factor that ignited the selloff was buried below the headline metrics in Zscaler's Q3 FY2026 earnings release: the company cut its full-year fiscal 2026 free cash flow margin guidance to 22.8%–23.3%, down sharply from its prior guidance of 26.5%–27%. The reason given was capital expenditure tracking in the high single digits as a percentage of revenue, a level that investors were not prepared for from a business long positioned as an asset-light, cloud-first platform. Management also disclosed it pulled forward planned investments into the fiscal fourth quarter, signaling the elevated spending is not a one-quarter anomaly but a deliberate strategic commitment. In Q3 alone, free cash flow margin came in at 16%, down from 18% in the same quarter a year earlier, reinforcing that margin pressure was already building before the guidance revision. The severity of the cut — nearly 400 basis points at the midpoint — triggered a re-rating of the stock's intrinsic value in real time.

Q3 Earnings: A Strong Beat Overshadowed

Zscaler's Q3 FY2026 operational results were genuinely strong by most measures. Total revenue reached $850.5 million, a 25% year-over-year increase that exceeded analyst expectations by approximately $14 million. Non-GAAP EPS came in at $1.08, clearing the analyst consensus of $1.01, while Annual Recurring Revenue grew 25% year-over-year to $3.525 billion, with net new ARR rising 24% to $166 million. Zscaler also raised its full-year FY2026 revenue outlook to $3.330–$3.333 billion, up from prior guidance of $3.309–$3.322 billion, and lifted adjusted EPS guidance to $4.10–$4.11, versus prior guidance of $3.99–$4.02. Non-GAAP operating margins hit a record 23% in the quarter. None of these positives, however, were powerful enough to offset the free cash flow shock that followed.

Organic Growth Concerns

A secondary pressure point amplifying the selloff is the question of organic revenue quality. Zscaler completed multiple acquisitions in recent quarters — including Red Canary, SPLXAI, and SquareX — which contributed inorganically to ARR growth. Excluding the Red Canary contribution, organic ARR growth trails the reported 25% headline figure by several percentage points, raising investor concern about whether Zscaler's core Zero Trust platform is truly accelerating or whether top-line growth is increasingly dependent on acquired revenue. This debate, which has persisted since the acquisitions were announced, intensified following the earnings release because the simultaneous cash flow margin compression makes the cost of those acquisitions — and their integration — harder to justify in the near term.

Analyst Reactions and Valuation Pressure

The earnings-driven move is expected to prompt a fresh round of analyst price target revisions on May 27. Going into the print, the average 12-month analyst price target for ZS stood at approximately $260.97 among 41 covering analysts, with the highest target at $390. The stock had rallied nearly 28% through May ahead of the earnings report, meaning it entered the print at a rich valuation that provided little cushion for negative surprises. With shares now trading near $140, well below the lowest consensus price targets entering the quarter, analysts covering ZS face a significant reset of their models and price targets. The prior pattern — Zscaler falling sharply after earnings then recovering as analysts defend the thesis — will be tested again, but the free cash flow cut introduces a more structural concern than previous post-earnings declines.

Market Context and Trading Activity

The initial after-hours reaction saw ZS fall approximately 17–19% before the decline extended further into the premarket session, ultimately compounding to the approximately 24% drop seen in early trading. Premarket volume was running well above the stock's typical pre-open levels, reflecting heavy institutional repositioning. The broader Nasdaq and cybersecurity sector did not experience comparable stress, making this a company-specific event driven entirely by the cash flow guidance miss rather than a macro or sector-wide catalyst. Peer names such as PANW and FTNT are being monitored for any sympathy reaction, though no comparable selling pressure has emerged in those names. From a technical standpoint, the selloff has broken ZS below multiple layers of support established during the May rally, resetting the technical picture significantly lower.

Trending AI Robots

For traders navigating sharp single-session moves like today's ZS decline, Tickeron's Trending AI Robots page provides a curated selection of the platform's strongest-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-driven bots covering thousands of tickers across a wide range of strategies — from momentum and trend-following to mean-reversion and pattern recognition — varying by timeframe, traded symbols, and performance metrics. Only bots demonstrating the most consistent live results under prevailing market conditions are featured in the trending section, distinguishing them from the broader catalog. Traders seeking a systematic, data-driven approach to volatile markets are encouraged to explore the full lineup and evaluate each bot's track record directly on Tickeron's platform.

What Comes Next for ZS

The primary near-term focus for ZS investors will be fiscal Q4 FY2026 results, expected in late August or early September 2026, where analysts will scrutinize whether CapEx tracks in line with management's revised projections or continues to surprise to the upside. The Q4 revenue guidance of $875–$878 million implies approximately 22% year-over-year growth, a modest deceleration from Q3's 25% pace that will keep growth trajectory questions in focus. Management's ability to articulate a clear, credible path back toward free cash flow margins in the mid-to-high 20s will likely determine whether the stock can stabilize or faces additional multiple compression. Broader enterprise IT spending trends, the competitive landscape in Zero Trust security — particularly against PANW and CRWD — and the pace of AI security deal wins will also be key variables as the company moves toward fiscal year-end. Macro uncertainty around enterprise technology budgets and any further developments regarding the integration of recent acquisitions remain material risk factors for the thesis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: ZS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ZS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ZS moved above the 200-day moving average on September 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 14, 2026. You may want to consider a long position or call options on ZS as a result. In 65 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for ZS just turned positive on September 15, 2026. Looking at past instances where ZS's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.

Following a +2.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZS advanced for three days, in 264 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

The Aroon Indicator entered an Uptrend today. In 149 of 234 cases where ZS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Bearish Trend Analysis

The 10-day RSI Indicator for ZS moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 30 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. ZS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.121) is normal, around the industry mean (20.462). P/E Ratio (0.000) is within average values for comparable stocks, (157.270). Projected Growth (PEG Ratio) (1.978) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (9.158) is also within normal values, averaging (103.889).

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), Twilio (NYSE:TWLO), NetApp (NASDAQ:NTAP), Okta (NASDAQ:OKTA), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.67B. The market cap for tickers in the group ranges from 48.8K to 3.83T. MSFT holds the highest valuation in this group at 3.83T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 27%. LHSW experienced the highest price growth at 67%, while HUBC experienced the biggest fall at -59%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -37%. For the same stocks of the Industry, the average monthly volume growth was 19% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 70
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 91
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
ZS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an antivirus & cloud security platform

Industry ComputerCommunications

Industry
Packaged Software
Address
120 Holger Way
Phone
+1 408 533-0288
Employees
8700
Web
https://www.zscaler.com
Interact to see
Advertisement
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.
AUGO shares are trading roughly 9% higher in Wednesday action, moving from a prior close of $66.42 to around $72.40 intraday. The stock’s advance extends a powerful year-long rally underpinned by record 2025 production, surging Adjusted EBITDA, and a recently declared cash dividend of $0.66 per share.
NAVN shares are surging approximately +25% in premarket trading on March 26, 2026, following a blockbuster earnings report released after the close of the prior session. Primary catalyst: Q4 fiscal year 2026 results delivered a significant beat — revenue of $178 million rose 35% year-over-year, surpassing analyst forecasts by nearly 10%.
OLPX surged approximately +50.38% in premarket trading on March 26, 2026, from a previous close of $1.33 to approximately $2.00, with an intraday premarket high of $2.03. The primary catalyst is a definitive acquisition agreement by German consumer goods giant Henkel AG to purchase Olaplex for $2.06 per share in an all-cash deal, valuing the company at approximately $1.4 billion.
TASK shares are down approximately -36% in premarket trading on March 26, 2026, the stock's official ex-dividend date for its special $3.65 per share cash dividend. The $3.65 special cash dividend — exceeding 25% of the stock's pre-ex-div market value — triggered a mandatory Nasdaq-prescribed price adjustment on today's open.
MLKN shares are down approximately 18.90% in premarket trading on March 26, 2026, falling to $15.70 from the prior session's close of $19.36. The primary catalyst is a double miss on both earnings and revenue in the company's fiscal Q3 2026 report released after the close on March 25.
Wave Life Sciences (WVE) shares are tumbling approximately 51% in premarket trading on March 26, 2026, from a prior close of $12.30 to approximately $6.03. The primary catalyst is the release of highly anticipated INLIGHT Phase 1 clinical data for WVE-007, the company's investigational INHBE GalNAc-siRNA obesity treatment, with results falling materially short of investor expectations.